Stay updated on AXS-05 in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AXS-05 in Alzheimer's Agitation Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference5%
- Check24 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with version update rather than additions of new substantive information.SummaryDifference0.6%
- Check38 days agoChange DetectedPage now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element was removed. This reflects a minor release with no substantive content changes.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%
- Check52 days agoChange DetectedThe web page has been updated to include new facility names and locations in Puerto Rico, as well as additional topics related to drug safety and Alzheimer's care. However, several previous location details and related resources have been removed.SummaryDifference6%
- Check60 days agoChange DetectedThe page has removed the section containing helpful links provided by Axsome Therapeutics, including links to the ADVANCE-2 Study Website and the Axsome Therapeutics Website.SummaryDifference0.7%
Stay in the know with updates to AXS-05 in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.